California Prop 38 Immunotherapy Research Bond Leads in Early Counts, Promising a 20% Patient Discount on Future Treatments
California's Proposition 38, an $8.4 billion bond for immunology and immunotherapy research on cancer, heart disease, and Alzheimer's disease, was leading with about 56% of the vote as counting continued Wednesday. Yes votes stood at 55.7%, or 4,181,327, to 44.2% no, with about 58% of votes counted…